“…The ratios of the quantitative assessment were 77%, 77% and 71% as the sensitivity, specificity and diagnostic accuracy, respectively, in comparison with 60%-100%, 77%-95% and 96% for qualitative assessment [15,17,28] . Despite the benefits of US, such as being noninvasive, widely available, low cost, ease of clinician use and interpretation, it has some limitations, such as a small field of view, limited use in accompanying chronic liver disease, inability to distinguish degree of fibrosis, cirrhosis and NASH, operator and equipment dependence, limited use in obese patients and low sensitivity when hepatosteatosis is less than 20%-30% [15,29] . In a recent study, Iijima et al [30] used an US contrast matter (Levovist; Sherling, Berlin) to distinguish between simple hepatosteatosis and NASH.…”